In the United Kingdom, researchers even found that there may be a link between a longer “symptom-to-call” time, higher peak hs-cTn I levels, and a lower six-month survival rate following myocardial infarction in COVID-19 patients [40]. This evidence concerns the gene TNNI3 and myocardial infarction.